Shares of Abbott Laboratories ABT rose 2.29% to $132.06 Wednesday, on what proved to be an all-around positive trading ...

Drugmaker Abbott India reported a jump in third-quarter profit on Wednesday, helped by strong demand for its gastrointestinal and heart disease medications, sending shares higher. The ...

The governor’s speech sets a broad agenda for the Legislature, including a nuclear renaissance and a Texas Cyber Command.

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks discussed by ...

Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Abbott is expected to post earnings of $1.07 per ...

Abbott Laboratories's intrinsic value estimated by Discounted Earnings model are arrived at by following assumptions and ...

The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Abbott Laboratories (NYSE: ABT) is a well-diversified health care company, with four distinct units: medical devices, ...

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and ...

With a trading volume of 5,249,687, the price of ABT is down by -0.19%, reaching $122.98. Current RSI values indicate that ...